"Ask the Expert” features answers by our experts to your clinical questions. Question: I want to know about first- and second-line chemotherapy regimens in metastatic triple-negative breast cancer.Answer: Single-agent chemotherapy is the most typical treatment for such patients, and there is no clear evidence that the order in which various drugs are used actually matters. That said, we try to enroll such patients in clinical trials, if at all possible.